Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2011 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Receives Approval from Health Canada for Hard Surface Disinfectant

WINNIPEG, MANITOBA--(Marketwire - Oct. 12, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
August 30, 2011 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Files New Patent on Bone Tissue Regeneration Invention

WINNIPEG, MANITOBA--(Marketwire - Aug. 30, 2011) - Highlights: Invention and patenting of a new bone tissue regenerating technology ...
July 26, 2011 08:43 ET | Source: Kane Biotech Inc.

DispersinB(R) Effective Against Superbug MRSA

WINNIPEG, MANITOBA--(Marketwire - July 26, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
July 14, 2011 09:22 ET | Source: Kane Biotech Inc.

Kane Biotech Appoints Interim CFO and Announces Grant of Options

WINNIPEG, MANITOBA--(Marketwire - July 14, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
July 07, 2011 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Submits DispersinB(R) Wound Spray Briefing Document to the FDA

WINNIPEG, MANITOBA --(Marketwire - July 7, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
June 29, 2011 12:17 ET | Source: Kane Biotech Inc.

Kane Biotech Announces New Board Members

WINNIPEG, MANITOBA--(Marketwire - June 29, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove...
May 31, 2011 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Awarded Contract by the United States Army to Develop Antibiofilm-Antimicrobial Wound Gel

WINNIPEG, MANITOBA--(Marketwire - May 31, 2011) -Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove...
May 06, 2011 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Changes to the Board of Directors

WINNIPEG, MANITOBA--(Marketwire - May 6, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and disperse microbial biofilms,...
April 15, 2011 14:23 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Closing of Private Placement Offering

WINNIPEG, MANITOBA--(Marketwire - April 15, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company"), a biotechnology company engaged in the development of products that prevent and remove...
April 06, 2011 09:30 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Increase to Private Placement Offering

WINNIPEG, MANITOBA--(Marketwire - April 6, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that...